Cultural differences in acceptability of a vaginal microbicide: a comparison between potential users from Nashville, Tennessee, USA, and Kafue and Mumbwa, Zambia by Rice, Valerie Montgomery et al.
© 2012 Montgomery Rice et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
HIV/AIDS - Research and Palliative Care 2012:4 73–80
HIV/AIDS - Research and Palliative Care
Cultural differences in acceptability of a vaginal 
microbicide: a comparison between potential 
users from Nashville, Tennessee, USA, and Kafue 
and Mumbwa, Zambia
Valerie Montgomery Rice1
Margaret C Maimbolwa2
Esther Munalula Nkandu2
Jacqueline Fleming 
Hampton3,*
Jae-Eun Lee4
James EK Hildreth5
1Morehouse School of Medicine, 
Atlanta, GA, USA; 2School of Medicine, 
University of Zambia, Lusaka, 
Zambia; 3Meharry Medical College, 
Center for AIDS Health Disparities 
Research, Nashville, TN, USA; 4RCMI 
Translational Research Network Data 
and Technology Coordinating Center, 
Jackson State University, Jackson, MS, 
USA; 5Dean, College of Biological 
Sciences, University of California 
Davis, Davis, CA, USA
Note: at the time the research was 
conducted, Dr Montgomery Rice was 
the Executive Director, Center for 
Women’s Health Research, Meharry 
Medical College, Nashville, TN, USA, 
and Dr Hildreth was the Director, 
Center for AIDS Health Disparities 
Research, Meharry Medical College, 
Nashville, TN
*Dr Fleming Hampton has passed 
away since this manuscript was 
written. We wish to honor her 
memory by including her as an author
Correspondence: Valerie Montgomery Rice 
Morehouse School of Medicine, 
720 Westview Drive, SW, Hugh Gloster 
Building, Suite 100 
Atlanta, GA 30310-1495 USA 
Tel +1 404 752 1728 
Fax +1 404 752 1594 
Email vmrice@msm.edu
Purpose: We sought to determine the relationship between acceptability of a hypothetical 
vaginal microbicide, cultural factors, and perceived HIV risk among African-American women 
in Nashville, TN, USA, and African women in Kafue and Mumbwa, Zambia.
Patients and methods: Women in both sites completed a survey. Regression analyses were 
performed on valid samples (Nashville, 164; Zambia, 101) to determine cultural differences 
affecting microbicide acceptability. Regression analyses also tested whether individual risk 
perception affected acceptability.
Results: In Zambia, 89.6% of women were willing to use a microbicide versus 81.6% in 
  Nashville (P , 0.0001). One cultural difference is that women in the Zambian cohort viewed 
risk of HIV infection as distinct from risk of acquiring STIs, with 48% believing they were 
certain to become infected with AIDS, compared to 4% of Nashville participants.
Conclusion: These results suggest a high degree of acceptability toward use of a vaginal 
microbicide to prevent HIV infection.
Keywords: HIV/AIDS, women, birth control, sexually transmitted infections
Introduction
African-American and African women are disproportionately affected by HIV-1. 
One potential woman-initiated method to prevent transmission of HIV-1 is use of a 
vaginal microbicide.1 However, without user acceptance, adherence is likely to be 
low. For this reason, acceptability studies have become key components of micro-
bicide   clinical studies. Earlier studies have defined acceptability as “use” and “use 
preferences.” More recently, acceptability trials have related acceptability to HIV risk 
perception2,3 and the effect of cross-cultural experiences.4,5
This article presents data from a social science study conducted in Nashville, TN, 
USA, and Kafue and Mumbwa, Zambia, to determine whether differences exist in 
levels of acceptability, cultural factors, and/or perceived risk of HIV-1 among potential 
users of a vaginal microbicide.
Methods
The microbicide acceptability study was conducted among African-American women 
living in Nashville, TN, USA, and among African women living in the Kafue and 
Mumbwa districts in Zambia. Each woman signed a consent form prior to p  articipating. 
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In Nashville, TN, USA, women were recruited through the 
use of email alerts, flyers, and those visiting the Center for 
Women’s Health Research. The women in Zambia were iden-
tified through local clinics and local leadership; the criterion 
was women who had children younger than age 5 years who 
were being brought to the district hospital for   vaccination. 
Meharry Medical School reviewed and approved the con-
sent forms for the participants in Nashville, TN, USA, as 
did the University of Zambia for participants from Zambia. 
  Participants completed a 49-question survey that captured 
their beliefs about use of a vaginal cream, foam, or gel that 
could be used during sexual intercourse to prevent HIV 
infection. They could refuse to answer any of the questions 
and in no case was a participant identified. In Zambia, two 
researchers administered the questionnaires, as they were 
familiar with languages used in each of the districts studied. 
Each woman was asked if she was willing to participate in the 
study and after meeting the inclusion criteria and c  onsenting, 
interviews were carried out in a private room. On comple-
tion of the interview, the participant was given K 70,000 
(US$15) for transport.
In Nashville, a request to participate in an online survey 
was sent to a predetermined email list of potential partici-
pants who were women aged 18–60 years who represented 
diverse socioeconomic and ethnic groups. The email list 
comprised Meharry students, faculty and employees and 
those women who had provided their email addresses to the 
Center for Women’s Health Research from previous visits 
to the center or a previous engagement at the Center for an 
educational or research activity. The survey was accessed 
via a Web address. The survey questionnaire comprised 65 
questions that focused on gaining knowledge from women 
regarding microbicides, preferences for use, and expectations 
for effectiveness and partner acceptability. Each woman 
entered her own responses, which were encrypted and stored 
in a password-protected database on a Meharry Web server. 
To maintain anonymity of survey respondents, subjects who 
took the survey online were not given incentives.
Major outcome measures
At the USA site, where the survey was completed online, the 
subjects read the introductory paragraph and then proceeded 
to answer the questions. At the Zambian site, because most 
women could not read, an introductory paragraph was read 
to them followed by each of the questions with the answers 
recorded, based on the response. Also at the Zambian site, 
both the product and the applicator were available for the 
purposes of demonstration. Use of tampons is common in 
Zambia, even in rural areas like Mumbwa; therefore, the 
participants were familiar with the concept of a vaginal 
  applicator. Microbicide acceptability was measured by   asking 
the Zambian participants to see, feel, and smell and/or taste 
the microbicide gel so as to determine their willingness to use 
the product that would be “placed” in the vagina to prevent 
HIV infection. At both sites, participants selected one of the 
following options: “Definitely yes,” “Probably,” “Probably 
not,” and “Definitely not.” A dichotomized variable (“Yes, 
definitely” versus all others) was used for the categorical 
data analysis.
Another measure for acceptability was derived by   asking 
participants to rate acceptability with using a microbicide 
under nine conditions describing its potential features 
(Table 1). To create a composite measure, we assigned 1 point 
to “Definitely unacceptable,” 2 to “Probably unacceptable,” 
Table 1 Conditional acceptability of microbicide
Condition Total  
n = 265
Nashville  
n = 164
Zambia  
n = 101
Chi-square*
n % n % n % Value P-value
If microbicide were a vaginal suppository 151 75.5 97 78.2 54 71.1 1.31 0.2523
If microbicide were a cream 158 77.8 91 72.2 67 87.0 6.06 0.0138
A small amount leaks out of your vagina after sex 99 52.1 69 57.0 30 43.5 3.23 0.0722
If the microbicide made your vagina wetter than  
you normally are during sex
124 62.6 102 83.6 22 28.9 59.77 ,0.0001
If the microbicide made you drier than you normally  
are during sex
65 33.3 27 21.8 38 54.3 56.84 ,0.0001
If the microbicide has a pleasant taste 146 80.2 92 80.7 54 79.4 0.04 0.8326
If the microbicide needs to be inserted at least 15 minutes  
before having sex
113 58.5 76 61.8 37 52.9 1.47 0.2259
If the microbicide is placed in the vagina with an applicator 156 80.0 101 90.6 55 58.3 25.69 ,0.0001
If the microbicide is placed in the vagina with the fingers 133 70.4 86 69.9 47 71.2 0.03 0.8527
Notes: Number is the frequency and proportion of participants who indicated that the specific condition was probably and definitely acceptable. *Chi-square test for the 
difference between Nashville and Zambia.
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3 to “Probably acceptable,” and 4 to “Definitely acceptable.” 
The conditional acceptability as a composite measure was 
generated by averaging the scores assigned to each condition. 
Cronbach’s alpha for responses from nine items was 0.79 
(0.88 for Nashville and 0.70 for Zambia), which was higher 
than 0.70 as a sign of acceptable internal consistency and 
reliability. The correlation coefficient between willingness-
to-use and composite conditional acceptability was 0.45 
(P , 0.0001), meaning that cross-structure validity of two 
acceptability measures was supported. The perceived risk for 
sexually transmitted infection (STIs) as a key independent 
variable was assessed by asking participants to indicate the 
extent of agreement with the 8 statements describing the 
sexually transmitted infection (Table 3). The participants 
checked one of the following options: “Strongly agree,” 
“Agree,” “Disagree,” and “Strongly disagree.” We used 
a dichotomized variable (agree versus disagree) for the 
analysis.
Statistical methods
Most statistical analyses were carried out using SAS version 
9.1 (SAS Institute Inc, Cary NC). Baseline characteristics 
and level of acceptability were compared between study 
sites using a t-test for continuous variables and Pearson chi-
square tests for categorical variables. To assess the attitude 
toward the potential features of the microbicide, frequency 
and percentages were calculated and bar charts used for 
graphical presentation.
To determine the association of acceptability with 
  background characteristics, perceived risk for acquiring 
STIs,   sexual behaviors, and history of STIs, we conducted 
a series of logistic regressions for dichotomized accept-
ability   (willingness-to-use) and a series of Analysis of Vari-
ance (ANOVA) for continuous acceptability   (composite 
conditional acceptability). Before we conducted the data 
analyses, we checked the normality of the composite 
  measure of acceptability. It was close to normal distribution 
(skewedness = 0.56 and   Kurtosis = 0.36). The results from log-
transformed data did not differ from those of nontransformed 
data. We reported the results from   nontransformed data. The 
regression analyses were separately performed by study sites to 
determine any cultural difference in factors impacting accept-
ability. For both logistic   regression and ANOVA, we used the 
  Generalized Linear Model (GLM) in which the acceptance was 
the dependent variable and   individual potential factor was the 
main   predictor. The following regression equation was used 
for the GLM: g(E[y]) = b0 + bmxm where g is the link function 
defining the relationship between the outcome and the linear 
predictor, which is binomial logit function for logistic regres-
sion and identity function for ANOVA; b0 is a parameter to 
estimate the intercept and bm is a parameter to estimate the 
contribution of main predictor to the outcome. We reported 
mean, standard deviation, F-value, and P-value for ANOVA 
and frequency, percent, odds ratio, 95% confidence interval, 
and P-value for logistic regression.
Results
Characteristics of participants
A total of 101 women from Kafue and Mumbwa districts, 
Zambia, and 164 from Nashville were included in the study. 
Major characteristics of participants at each study site are 
summarized in Table 2. The average age was higher in 
Nashville (36 years) than in Zambia (31 years). A higher 
proportion of participants in Nashville were more educated, 
employed/doing paid work, had medical insurance, and a 
d octor or other medical provider to see regularly. The major-
ity of the participants from Zambia had low education. The 
study sites in Zambia were from the rural parts of Zambia 
which contributed to their low economical and educational 
status. Further, participants from Zambia were more likely to 
be married/live with partners than those from Nashville.
Attitude toward use of potential features 
of microbicide
If participants replied they and their partners had never used 
a vaginal method of birth control – eg, cream, foam, gel, 
vaginal capsule (suppository), or sponge – they were asked 
to cite reasons for non-use. A total of 249 valid reasons for 
non-use of the potential microbicide features were identi-
fied from 175 participants. “Happy with other methods of 
birth control” was found to be the most frequent reason for 
non-use, followed by “never heard of them,” “too messy,” 
“not effective in preventing pregnancy,” and “not enough 
information on the product.” These five reasons comprised 
70% of the total.
However, this pattern differed between study sites. In 
Nashville, “being happy with other methods” (39%) was the 
most frequent, followed by “too messy” (12%), “never heard 
of them” (10%), and “not effective in preventing pregnancy 
(9%) and disease (6%).” In Zambia, two reasons related to 
lack of information (“never heard of them,” 24%, and “not 
enough information on the product,” 14%) were the most 
frequent, followed by “not effective in preventing pregnancy” 
(9%), “happy with other methods” (8%) and “not effective in 
preventing disease” (7%). While suspicion about its effective-
ness was a greater reason in Nashville, lack of information was 
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greater in Zambia. The five most frequent reasons comprised 
76% of the total among the Nashville participants, compared 
with 63% among those in Zambia, suggesting that more 
diverse reasons were identified in Zambia than in Nashville.
Specific reasons to like a birth control cream, foam, gel, 
vaginal capsule (suppository), or sponge for the purposes of 
preventing HIV acquisition and/or pregnancy among partici-
pants from both sites are summarized in Figure 1. A total of 
189 valid reasons were identified from 56 participants. “Easy 
to use” was the most frequent reason to like, followed by 
“affordable,” “no allergic reaction,” “convenient,” “not need 
a doctor to get it,” and “effective at preventing pregnancy.” 
Among the top 12 reasons, four were convenience-related 
(“easy to use,” “not need a doctor to get it,” “not too messy,” 
and “being convenient”); three were related to potential side 
effects (“non-allergic reaction by user and partner,” “no 
burning,” and “wetter vagina”) two were financial (“afford-
able” and “no insurance needed”); and one was related to 
effectiveness (“preventing pregnancy”).
Acceptability of microbicides
The majority of participants (85%) indicated they were 
  willing to consider using a product that could be “placed” in 
the vagina that could prevent sexually transmitted   infections 
and HIV/AIDS. The acceptance rate was higher in Zambia 
than in Nashville (89.6% for Zambia and 81.6% for   Nashville; 
P , 0.0001). Those from Zambia had stronger willingness 
than those from Nashville. While 81% of Zambian women 
indicated that they would “Definitely” consider it, only 53% 
participants from Nashville did.
We asked participants to rate their level of acceptability 
with using a microbicide under the nine conditions describ-
ing its potential features. Table 1 shows the frequency and 
proportion of participants who indicated that the specific 
condition was “probably” or “definitely” acceptable. The 
participants rated the highest acceptability for “pleasant 
taste” and “placement in the vagina with an applicator” 
and only one in three (33.3%) indicated that “dryness” was 
acceptable. This pattern was different between sites. While a 
higher acceptance was reported on “wetness” and “placement 
in vagina” among participants in Nashville, participants in 
Zambia rated higher on “cream” and “dryness.” “Wetness” 
and “placement in vagina” were one of the highest rated 
conditions in Nashville; however, the Zambian cohort rated 
this lowest. While the majority (54.3%) of Zambian women 
indicated that “dryness” was acceptable, only one in five 
(21.8%) of participants in Nashville concurred. Mean scores 
of composite conditional acceptability were 2.7 (SD = 0.7). 
Table 2 Characteristics of women enrolled in each study site (n = 265)
Characteristics Nashville (n = 164) Zambia (n = 101) Chi-square
n % n % Value P-value
Marital status
  Not married/live alone 73 60.3 24 24.0 29.3446 ,0.0001
  Married/live with partner 48 39.7 76 76.0
Years of education
  Low education (1–12 years) 6 5.3 93 93.9 178.6293 ,0.0001
  High education (13+ years) 108 94.7 2 2.1
Paid work
  Unemployed/non-paid work 28 23.0 76 79.2 68.0561 ,0.0001
  Employed/paid work 94 77.1 20 20.8
Mean age (SD) 36.4 12.6 31.1 10.4   0.0015
Any medical insurance
  No 10 9.1 96 96.0 158.2717 ,0.0001
  Yes 100 90.9 4 4.0
See medical professionals regularly
  No 15 12.2 78 78.0 98.2426 ,0.0001
  Yes 108 87.8 22 22.0
More than 12 months since last period
  No 86 74.1 95 94.1 15.4846 ,0.0001
  Yes 30 25.9 6 5.9  
Menopausal therapy (if reply to previous question about last period is “yes”)
  No 119 97.5 90 96.8 0.1144 0.7352
  Yes 3 2.5 3 3.2
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The scores were slightly higher among the participants in 
Nashville than in Zambia (2.8 for Nashville and 2.6 for 
Zambia; P = 0.0855).
Association of acceptability with major 
characteristics
The participants indicated a high willingness-to-use, regard-
less of subgroups of marital status, years in education, 
employment status, and availability of medical professionals. 
However, willingness-to-use differed by the subgroups of age 
and site. The separated logistic regression analyses suggested 
that older participants (aged 40+ years) in Nashville were 
more likely to be willing to use than their younger coun-
terparts aged 18–39 years (71.4% for older and 42.4% for 
younger; P = 0.004), while younger participants in Zambia 
were more willing to use than older ones (58.8% for older 
and 86.1% for younger; P = 0.013).
Most of the characteristic variables were not significantly 
associated with composite measure of conditional acceptabil-
ity in either site with only one exception; in Zambia, women 
who were not married or lived alone reported a higher condi-
tional acceptability than their counterparts (P = 0.036).
Association of acceptability  
with perceived risk for STIs
A woman’s willingness-to-use a vaginal microbicide was not 
associated with degree of agreement with eight statements 
describing perceived risk for STIs, with one exception: in 
Zambia, 87% of those who agreed “feel almost certain they 
will get AIDS” and indicated they were willing to use it, 
while 68% of those who disagreed indicated that they were 
willing to do so (P = 0.049).
Table 3 shows the results of ANOVA analyses to   determine 
the association between conditional acceptability and per-
ceived risk for acquiring STIs. Women who perceived a high 
risk for STIs were more likely to accept the potential features of 
a vaginal microbicide. However, this pattern differed between 
study sites. In Nashville, while those who agreed that “luck 
plays a big part in determining if I can keep from getting a 
sexually transmitted infection” reported a higher mean score 
Table 3 Results of GLM separated by sites to determine association between conditional acceptability and perceived risk for 
acquiring STIs
Nashville Zambia
Conditional  
acceptability
ANOVA Conditional  
acceptability
ANOVA
Mean SD F P-value Mean SD F P-value
Regular consultations “checks” and wellness exams with a health care provider is the best way for me to avoid a sexually transmitted disease
  Disagree 2.8 0.6 0.08 0.7810 2.3 0.9 3.9 0.0515
  Agree 2.8 0.6     2.7 0.8  
No matter what I do I am likely to get a sexually transmitted infection
  Disagree 2.8 0.6 0.74 0.3902 2.5 0.9 0.9 0.3497
  Agree 3.0 0.8     2.7 0.9  
My partner has a lot to do with my getting or avoiding a sexually transmitted disease
  Disagree 2.8 0.6 0.00 0.9477 2.3 0.9 2.8 0.1012
  Agree 2.8 0.6     2.7 0.8  
Luck plays a big part in determining if I can keep from getting a sexually transmitted infection
  Disagree 2.8 0.6 5.59 0.0197 2.6 0.7 0.0 0.9276
  Agree 3.4 0.6     2.6 0.9  
If I take the right actions, I can avoid getting a sexually transmitted infection
  Disagree 2.9 0.2 0.04 0.8355 2.5 1.0 0.3 0.5812
  Agree 2.8 0.6     2.7 0.8  
I refuse to have sex if my partner refuses to use a condom or latex barrier
  Disagree 2.8 0.5 0.02 0.8889 2.3 0.8 10.0 0.0023
  Agree 2.8 0.6     2.9 0.8  
I feel almost certain that I will get AIDS
  Disagree 2.8 0.6 4.04 0.0467 2.3 0.8 4.5 0.0363
  Agree 2.3 0.7     2.7 0.9  
My past behavior puts me at high risk for getting HIV or AIDS
  Disagree 2.7 0.6 1.49 0.2243 2.4 0.7 16.6 0.0001
  Agree 2.9 0.5     3.1 0.8
Abbreviations: STIs, sexually transmitted infections; GLM, generalized linear model.
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of conditional acceptability than those who disagreed with that 
statement. Those who agreed with “I feel almost certain that 
I will get AIDS” reported a lower mean score than those who 
disagreed. In Zambia, those who agreed with the following 
statements: “Regular consultation,” “checks,” and “wellness 
exams with a health care provider is the best way for me to 
avoid a sexually transmitted disease,” “I refuse to have sex if my 
partner refuses to use a condom or latex barrier,” “I feel almost 
certain that I will get AIDS,” and “My past behavior puts me 
at high risk for getting HIV or AIDS” reported a significantly 
higher mean acceptability than those who disagreed with the 
same statements, respectively.
Among women in Zambia, 74% of those who perceived 
they had a high risk for STIs responded that they would get HIV 
versus 20% of the women in Nashville. However, this com-
parison may not be statistically meaningful, as only 5 women 
in Nashville perceived themselves at high risk for STIs.
Association of acceptability with sexual 
behaviors
Willingness-to-use was marginally associated with condom 
use with a male partner in Nashville (65% for never users 
of condoms and 48% for ever users; P = 0.076) and use of 
barrier methods in Zambia (60% for never users and 53% 
for ever users; P = 0.090).
A series of ANOVA analyses determined that condi-
tional acceptability was significantly associated with sexual 
  behaviors. In Nashville, women who had one or more sex 
partners within the past 30 days and had never used a condom 
with a male partner were more likely to report a higher mean 
conditional acceptability than their counterparts, respectively. 
In Zambia, a significantly higher mean acceptability was 
found among those who ever used a barrier method and had 
never used a condom due to discomfort in asking a partner 
to use than their counterparts, respectively.
Association of acceptability with STIs
A higher proportion of willingness-to-use was found among 
those who had a history of one or more STIs (65% for one or 
more STIs and 46% for non-STIs; P = 0.041) only among the 
Nashville cohort. No significant association of STI history 
with conditional acceptability was reported in either site.
Discussion
One underexplored area of behavioral and social science 
research is an understanding of the social contexts in which a 
Zambia
Partner not having a side effect
Not need insurance to get it
Vagina felt wetter
Not too messy
Partner could not tell if you were using it
Not feel burning while using
Effective at preventing pregnancy
Not need a doctor to get it
Convenient
No allergic reaction
Affordable
0.0 2.0 4.0 6.0 8.0 10.0 12.0
Easy to use
Nashville
Total
Figure 1 Proportion of top 12 reasons to like a vaginal microbicide cited by women enrolled in the study.
Notes: “Effective at preventing pregnancy,” and “Not need a doctor to get it” were not cited as reasons by the Zambian cohort.
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vaginal microbicide will be used. In this study, we endeavor 
to provide some information.
Although the majority of women at either site,   Nashville 
(78.2%) and Zambia (62.6%), believed that their past behavior 
did not put them at risk for acquiring HIV or AIDS (P , 0.014); 
48% of the Zambian cohort versus 4% of the Nashville cohort 
felt certain they would get AIDS (P , 0.0001). Among those 
in the Zambian cohort who felt they would acquire HIV , 
87% indicated they were willing to use a vaginal microbicide 
product. In contrast, .90% of women in both cohorts felt 
that if they took the right actions, they could avoid getting an 
STI. No difference was observed between the cohorts in the 
percentage of women indicating they could refuse to have sex 
if their partner “refuses to use a condom.”
These findings suggest a high degree of acceptability 
toward use of a vaginal microbicide to prevent HIV infection. 
This study also demonstrated that women in the Zambian 
cohort view the risk of HIV infection as distinct from the 
risk of acquiring STIs and believe themselves to be limited 
in their ability to control whether they will be infected by 
HIV . This could be due to the fact that in Zambia, the two 
diseases are managed separately during treatment and are 
not particularly seen as STIs at the community level. In 
Zambia, the questionnaire used asked about HIV/AIDS and 
STI as separate questions and the outcomes for the Zambian 
cohort showed that the women viewed HIV infection as being 
completely different from acquiring an STI. HIV infection 
was not considered an STI but as a separate condition even 
though associated with their sexuality.
In Zambia, some of the women do not have full control of 
their health due to social demands on accepted behavior that a 
woman should demonstrate in a marriage setting. They may, in 
some cases, not have the capacity to negotiate for condom use 
with their partners, as this may be perceived to imply promiscu-
ity. Most of the women reported they were married and many 
viewed themselves at risk of contracting HIV if their partners 
had other sexual partners.6 For those unable to negotiate mutual 
monogamy or condom use, the use of vaginal microbicide gels 
have been widely studied for decades with primarily limited 
success. Results of a study in sub-Saharan Africa with teno-
fovir gel, an antiretroviral microbicide, suggest its use could 
potentially fill an important HIV prevention gap.7 Karim et al 
found gel acceptability to be 97.4%, with 97.9% indicating 
they would use tenofovir gel if it prevented HIV . However, they 
found that women with the highest gel adherence also tended to 
have the lowest reported coital frequency, with HIV incidence 
rates comparable (in the placebo arm) with those who reported 
much higher coital frequencies.7 The investigators noted this 
reflected both the study’s location at the epicenter of southern 
Africa’s HIV epidemic in the KwaZulu–Natal province and the 
very high-risk sex the women engaged in with migrant men. 
While ability of the coitally-related tenofovir gel to prevent 
HIV infection among this group was substantial, its decline 
in effectiveness after 18 months needs further investigation, 
including whether less gel was applied or adherence declined 
over time.
One recent study that investigated vaginal practices and 
associations with barrier methods and gel use among sub-
Saharan African women enrolled in an HIV prevention trial 
found vaginal washing, wiping, and insertion of dry or absor-
bent material were all independently and inversely associated 
with consistent diaphragm and gel use with condom use. Van 
der Straten et al8 concluded that this knowledge, along with 
a better understanding of the sociocultural context in which 
these practices are embedded, could help improve education 
strategies to address potential modifiable behaviors.
Educational attainment is generally one of the key 
indicators for analyzing women’s health status. Men and 
women tend to sustain a perpetual gender inequality within 
the family and society at large. Overall, the level of educa-
tion in Zambia is higher among men than women and the 
proportion of women without education (ie, no schooling 
whatsoever) ranges from 4% for women aged 15–20 years 
to 20% for women aged 45–49.6 Therefore, the women in 
the specific research setting in Zambia generally lack the 
capacity to demand their rights, which often has a negative 
impact on their health. In fact, being married is in itself a 
“risk factor,” as they do not have a say in or control over 
the behavior of their partners. There are also high dropout 
rates among girls at primary and secondary levels, which 
may explain the reason why women believe themselves to 
be limited in their ability to control whether they will be 
infected by HIV or not, as marriage in the rural setting is 
seen as an economic gain.6
There were more women in Nashville than in Zambia who 
accepted the condition that the microbicide made the vagina 
wetter than normal during sex. This is due to the fact that 
in some African countries, the preference by men for a tight 
vagina, associated with virginity or fidelity, is emphasized 
via socialization. A study by Montgomery et al9 revealed 
that a number of male partners of women initiating gel use 
said that the added lubrication made it feel as though their 
partners had been sleeping with other men. For this reason, 
women said that if they did not tell their partners, their 
partners would not trust them and may think the women had 
been unfaithful.9
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Study limitation
The study was conducted with few women in two rural 
sites and, as such, the results of this study cannot be gen-
eralized for Zambia. Another limitation in interpreting 
the results of the study is that data collection methods 
differed between countries (online survey for USA and 
personal interview for Zambia). Since online surveys 
provide respondents anonymity, results may reflect more 
honest answers to sensitive topics. However, a previous 
study10 has suggested that point estimation, but not pat-
terns of associations, may be affected by the difference 
in survey methods. Another limitation is that because 
the study results resorted to quantitative data by asking 
close-ended questions, the full meaning of the results may 
not be clear, nor is cultural context entirely evident. This 
manuscript uses data based on the qualitative interviews 
to extrapolate the meaning of the results.
Conclusion
This study illustrates that women are willing to use the 
microbicide gel. However, there is a need to create awareness 
so that women can read about it, or have centers where they 
can go (preferably in a health care center or a community 
center) to access information on microbicide gels, especially 
in the Zambia site, where inadequate information was cited 
as a significant problem. Further, engaging men in the 
use of microbicide for a couple would contribute towards 
adherence so the women (mainly in the Zambian setting) 
would not live in fear of being accused of being unfaithful. 
The effectiveness of the gel was expressed as a concern 
for the women in Nashville and this could be addressed by 
ensuring that the pharmacologic properties are explained 
through literature.
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